Almirall, S.A. (OTCMKTS:LBTSF) Sees Significant Growth in Short Interest

Almirall, S.A. (OTCMKTS:LBTSF) was the recipient of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling 104,200 shares, a growth of 23.8% from the July 31st total of 84,200 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Almirall Price Performance

Almirall stock remained flat at $9.51 during trading on Friday. The business’s 50 day simple moving average is $9.51 and its two-hundred day simple moving average is $9.51. Almirall has a fifty-two week low of $8.85 and a fifty-two week high of $10.18.

About Almirall

Almirall, SA, a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations.